Cargando…
Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes
Branched-chain amino acid (BCAA) catabolism has been considered to have an emerging role in the pathogenesis of metabolic disturbances in obesity and type 2 diabetes (T2D). Several studies showed elevated plasma BCAA levels in humans with insulin resistance and patients with T2D, although the underl...
Autores principales: | Vanweert, Froukje, Schrauwen, Patrick, Phielix, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356071/ https://www.ncbi.nlm.nih.gov/pubmed/35931683 http://dx.doi.org/10.1038/s41387-022-00213-3 |
Ejemplares similares
-
A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes
por: Vanweert, Froukje, et al.
Publicado: (2022) -
The Association between Circulating Branched Chain Amino Acids and the Temporal Risk of Developing Type 2 Diabetes Mellitus: A Systematic Review & Meta-Analysis
por: Ramzan, Imran, et al.
Publicado: (2022) -
The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity
por: Vanweert, Froukje, et al.
Publicado: (2021) -
Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD
por: S. Sonnet, Davis, et al.
Publicado: (2016) -
Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
por: Tanase, Daniela Maria, et al.
Publicado: (2023)